Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now later-stage tilt small index

Arthroplasty: later-stage trial registry

1 of 6 indexed Arthroplasty trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Arthroplasty: 6 US clinical trials tracked, 1 recruiting.

Arthroplasty is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Rush University Medical Center, running 2 of these trials.

Enrollment posture brief

Registry condition arthroplasty

OPEN 1 | RECR 17% | LATE 1 | EARLY 0 | RANK #2866 | SPON 2

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Arthroplasty (this)17%
Open-enrollment share among volume-matched conditions near Arthroplasty

Arthroplasty lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Arthroplasty on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Arthroplasty is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Arthroplasty research.

    Rush University Medical Center accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Arthroplasty enrolment sits around 168 participants.

    Median target enrolment is 168 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Arthroplasty research is mostly interventional.

    6 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 41

Phase Distribution

PhaseTrial count
Phase 4 1

Named interventions

Most-linked intervention names on Arthroplasty records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Saline Lavage Procedure
1 trials
Betadine Lavage Procedure
1 trials
Spinal Procedure
1 trials
General Procedure
1 trials
Continuous Adductor Canal Block Procedure
1 trials
Epidural Procedure
1 trials
Triathlon Tritanium Cone Augments Device
1 trials
Chronic Disease Self-Management Behavioral
1 trials

US sites by state

Facility locations filed on Arthroplasty trials. A trial with sites in several states counts in each.

Illinois 3 trials
Pennsylvania 2 trials
Ohio 2 trials
Missouri 2 trials
Michigan 2 trials
Florida 2 trials
Wisconsin 1 trials
Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Arthroplasty page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Arthroplasty condition card totals 6 registered trials; most-linked intervention Saline Lavage; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.